Asset Management One’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.9M | Sell |
253,003
-4,960
| -2% | -$345K | 0.05% | 325 |
|
|
2025
Q4 | $17.4M | Sell |
257,963
-6,059
| -2% | -$392K | 0.05% | 318 |
|
|
2025
Q3 | $17.8M | Buy |
264,022
+9,237
| +4% | +$731K | 0.05% | 318 |
|
|
2025
Q2 | $22.2M | Buy |
254,785
+1,430
| +0.6% | +$112K | 0.07% | 252 |
|
|
2025
Q1 | $17.3M | Buy |
253,355
+9,980
| +4% | +$814K | 0.06% | 300 |
|
|
2024
Q4 | $19.5M | Buy |
243,375
+7,901
| +3% | +$585K | 0.07% | 259 |
|
|
2024
Q3 | $15.8M | Buy |
235,474
+22,268
| +10% | +$1.83M | 0.06% | 319 |
|
|
2024
Q2 | $24.2M | Buy |
213,206
+1,421
| +0.7% | +$180K | 0.09% | 193 |
|
|
2024
Q1 | $29.4M | Sell |
211,785
-7,888
| -4% | -$992K | 0.11% | 163 |
|
|
2023
Q4 | $27.3M | Sell |
219,673
-4,342
| -2% | -$444K | 0.11% | 170 |
|
|
2023
Q3 | $20.9M | Buy |
224,015
+4,170
| +2% | +$470K | 0.09% | 200 |
|
|
2023
Q2 | $28.3M | Sell |
219,845
-8,003
| -4% | -$968K | 0.12% | 161 |
|
|
2023
Q1 | $26.5M | Sell |
227,848
-3,270
| -1% | -$366K | 0.12% | 168 |
|
|
2022
Q4 | $25.9M | Sell |
231,118
-7,037
| -3% | -$773K | 0.13% | 164 |
|
|
2022
Q3 | $19.2M | Sell |
238,155
-6,569
| -3% | -$556K | 0.1% | 206 |
|
|
2022
Q2 | $18.2M | Buy |
244,724
+26,564
| +12% | +$2.42M | 0.09% | 233 |
|
|
2022
Q1 | $27.9M | Sell |
218,160
-6,248
| -3% | -$683K | 0.11% | 185 |
|
|
2021
Q4 | $30M | Buy |
224,408
+5,888
| +3% | +$846K | 0.1% | 192 |
|
|
2021
Q3 | $29.9M | Sell |
218,520
-4,492
| -2% | -$566K | 0.11% | 182 |
|
|
2021
Q2 | $23.8M | Buy |
223,012
+128
| +0.1% | +$12.3K | 0.09% | 232 |
|
|
2021
Q1 | $20M | Sell |
222,884
-1,264
| -0.6% | -$119K | 0.08% | 254 |
|
|
2020
Q4 | $20M | Buy |
224,148
+7,888
| +4% | +$704K | 0.08% | 246 |
|
|
2020
Q3 | $22.3M | Buy |
216,260
+7,004
| +3% | +$732K | 0.1% | 192 |
|
|
2020
Q2 | $21.2M | Sell |
209,256
-23,144
| -10% | -$2.07M | 0.1% | 193 |
|
|
2020
Q1 | $15.6M | Buy |
232,400
+9,108
| +4% | +$567K | 0.09% | 216 |
|
|
2019
Q4 | $12.2M | Sell |
223,292
-14,824
| -6% | -$703K | 0.06% | 357 |
|
|
2019
Q3 | $8.88M | Buy |
238,116
+320
| +0.1% | +$12.4K | 0.04% | 430 |
|
|
2019
Q2 | $8.91M | Buy |
237,796
+22,616
| +11% | +$711K | 0.04% | 429 |
|
|
2019
Q1 | $6.41M | Sell |
215,180
-411,672
| -66% | -$14.5M | 0.03% | 504 |
|
|
2018
Q4 | $18.8M | Buy |
626,852
+596,612
| +1,973% | +$18.9M | 0.04% | 426 |
|
|
2018
Q3 | $1.08M | Sell |
30,240
-2,600
| -8% | -$80.6K | ﹤0.01% | 885 |
|
|
2018
Q2 | $777K | Buy |
32,840
+17,520
| +114% | +$371K | ﹤0.01% | 952 |
|
|
2018
Q1 | $284K | Buy |
15,320
+3,364
| +28% | +$49.7K | ﹤0.01% | 989 |
|
|
2017
Q4 | $172K | Sell |
11,956
-517,096
| -98% | -$6.72M | ﹤0.01% | 972 |
|
|
2017
Q3 | $6.45M | Buy |
529,052
+10,476
| +2% | +$185K | 0.02% | 720 |
|
|
2017
Q2 | $9.48M | Buy |
518,576
+4,168
| +0.8% | +$77K | 0.02% | 601 |
|
|
2017
Q1 | $10.9M | Buy |
514,408
+4,992
| +1% | +$97.4K | 0.03% | 563 |
|
|
2016
Q4 | $7.61M | Buy |
509,416
+220,164
| +76% | +$3.9M | 0.02% | 646 |
|
|
2016
Q3 | $6.35M | Sell |
289,252
-6,256
| -2% | -$139K | 0.09% | 239 |
|
|
2016
Q2 | $5.84M | Buy |
+295,508
| New | +$5.03M | 0.09% | 255 |
|
Other funds holding DXCM
VCM
VPM
Asset Management One's DXCM Position: Q1 2026 in Review
Asset Management One reduced its DexCom (DXCM) stake by 1.9% in Q1 2026, selling an estimated $345K and leaving 253,003 shares worth $15.9M. The position accounts for 0.05% of the portfolio, ranked #325.
Asset Management One first reported a position in DXCM in Q2 2016 and has held it in 40 quarters since. The position peaked at $30M in Q4 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Asset Management One held 253,003 shares of DexCom worth $15.9M as of Q1 2026.
- Asset Management One sold 4,960 DexCom shares in Q1 2026, an estimated $345K.
- DexCom made up 0.05% of Asset Management One's portfolio in Q1 2026, its #325 holding.
- Asset Management One first reported a position in DexCom in Q2 2016 and has held it in 40 quarters since.
- Asset Management One's DexCom position peaked at $30M in Q4 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.